2nd European Congress on Hematology and Blood Disorders
Event on: November | 10-11 | 2022
Millennium Hotel Paris Charles De Gaulle, Paris, France
Biomarker is a measurable meter of the severity or presence of some disease state. More generally a biomarker can be used as an indicator of a physiological state or a specific disease of an organism. Biomarkers in hematology are useful to identify or diagnose blood diseases in animals.
Cancer biomarkers are biological molecules formed by the body or tumor in a person with cancer. Biomarker testing helps describe alterations in the tumor. Biomarkers can be DNA, RNA, protein or metabolomics profiles that are definite to the tumor.
Related Tags: Hematology Conference | Hematology conferences 2022 | Hematology conferences | Hematology conferences 2022 | Hematology Congress | Hematology Congress 2022 | Hematology meetings | Hematology meeting 2022 | Hematology summit | Hematology summit 2022 | Leukemia conference | Leukemia conferences | Leukemia conference 2022 | Leukemia conferences 2022 | Leukemia congress | Leukemia congress 2022 | Leukemia meeting | Leukemia meetings | Leukemia meeting 2022 | Leukemia meetings 2022 | Leukemia summit | Leukemia summit 2022 | Lymphoma congress | Lymphoma congress 2022 | Lymphoma summit | Lymphoma summit 2022 | Lymphoma meeting | Lymphoma meeting 2022 | Myelofibrosis | Myelofibrosis 2022 | Myelofibrosis congress | Myelofibrosis congress 2022
Related Associations: American Academy of Hospice and Palliative Medicine | American Association for Cancer Education | Australasian Society of Blood Transfusion | Austrian Society of Hematology and Oncology | Croatian Hematology and Blood Transfusion Society | Cyprus Society of Haematology | Ceská Hematologická Spolecnost CLS JEP